To isolate Streptomyces tendae mutants blocked in the biosynthesis of the nikkomycin nucleoside base 4-formyl-4-imidazoline-2-one, an assay was developed to detect the formation of nikkomycins containing this base during growth on solid medium. The assay is based on the reaction of the 4-formylimidazolonestructure of nikkomycinswith the aldehyde reagent barbituric acid leading to red-colored products. Among18,000 AT-methyl-JV'-nitro-TV-nitrosoguanidine treated clones tested in the barbituric acid assay, weisolated one mutant which was incapable of forming any nikkomycins containing the 4-formylimidazolone base (nikkomycins Cx, X and I) but instead produced nikkomycins containing uracil (nikkomycins C, Z and J). led to the isolation of Tu901/AECl and AEC2which produced exclusively nikkomycins Kz and Kx. According to their nikkomycin spectrum, these strains were blocked at the hydroxylation step occuring at the pyridyl residue during biosynthesis of the nikkomycin amino acid.
ISOLATION OF STREPTOMYCES TENDAE MUTANTS
(Received for publication February 1 8, 1989) To isolate Streptomyces tendae mutants blocked in the biosynthesis of the nikkomycin nucleoside base 4-formyl-4-imidazoline-2-one, an assay was developed to detect the formation of nikkomycins containing this base during growth on solid medium. The assay is based on the reaction of the 4-formylimidazolonestructure of nikkomycinswith the aldehyde reagent barbituric acid leading to red-colored products. Among18,000 AT-methyl-JV'-nitro-TV-nitrosoguanidine treated clones tested in the barbituric acid assay, weisolated one mutant which was incapable of forming any nikkomycins containing the 4-formylimidazolone base (nikkomycins Cx, X and I) but instead produced nikkomycins containing uracil (nikkomycins C, Z and J).
In addition, we isolated strains with mutations affecting the biosynthesis of 2-amino-4-hydroxy-4-(5-hydroxy-2-pyridyl)-3-methylbutyric acid, the unusual amino acid of nikkomycins Z, X, J and I. By analyzing colonies derived from single spores or protoplasts of S. tendae Tu901/395, a mutant producing besides nikkomycins Z, X, J and I, also nikkomycins Kz/Kx and Oz/Ox, we obtained strains which only formed nikkomycins Kz/Kz and OJOXwith 2-amino-4-hydroxy-4-(2-pyridyl)butyric acid and 2-amino-4-hydroxy-4-(5-hydroxy-2-pyridyl)-butyric acid as amino acids. Mutation of such a strain (Tu901/395-ll) by UV365lim in the presence of 8-methoxypsoralen and selection of 5-2-aminoethyl-L-cysteine-resistant clones led to the isolation of Tu901/AECl and AEC2which produced exclusively nikkomycins Kz and Kx. According to their nikkomycin spectrum, these strains were blocked at the hydroxylation step occuring at the pyridyl residue during biosynthesis of the nikkomycin amino acid.
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Nikkomycins belong to the nucleoside peptide antibiotics and act as potent inhibitors of chitin synthetases from fungi and insects1~4). Streptomyces tendae Tu901 produces a spectrum of various nikkomycins with 4-formyl-4-imidazoline-2-one and uracil as variable bases5>6). The nucleoside moiety of biologically active nikkomycins produced by the wild type as major components is peptidically linked to the unusual amino acid 2-amino-4-hydroxy-4-(5-hydroxy-2-pyridyl)-3-methylbutyric acid (nikkomycin D, Fig. 1 ). Studies on the biosynthesis of nikkomycins revealed that the imidazolone base is derived from L-histidine7) and uracil from pyrimidine metabolism8). Furthermore, L-lysine was shown to be the precursor of the pyridyl residue and the attached hydroxymethylene carbon in nikkomycin D9). There is little knownabout enzymatic reactions and intermediate structures of nikkomycin biosynthesis. Therefore we decided to screen for mutants blocked in nikkomycin biosynthesis which could be employed as hosts for cloning experiments to isolate nikkomycin biosynthetic genes. We describe the isolation of strains of S. tendae with mutations affecting the biosynthesis of the imidazolone base and nikkomycin D. Biologically active (A) and inactive (B) structures.
Materials and Methods

Organisms and Mutagenesis
The wild type strain S. tendae Tii901/8c was obtained from the Streptomyces Culture Collection of the Institute of Microbiology I, University of Tubingen, FRG. The strain Tii901/395 was derived from Tii901/8c10). Spores of Tii901/8c were mutagenized by iV-methyl-N'-nitro-iV-nitrosoguanidine (NTG) according to Delic et aLn\ 109 spores were incubated at 30°C for up to 60 minutes in 1 ml 0.05 m Tris-maleic acid, pH 9.0 containing 2 mg NTG.
Mutants were selected among the 2% survivors. Mutagenesis with UVlight at 365 nmin the presence of 8-methoxypsoralen (MOP) is described by Townsend et al.12\ Among the 0.1 % survivors analog-resistant mutants were selected on minimal medium13) with 250 jug/ml S-2-aminoethyl-L-cysteine.
Culture Conditions HAmedium consisting of0.4 % yeast extract, 0.4% glucose, 1 % malt extract and 2% agar, pH 7.2 was used for growth of strains on solid medium. To investigate the nikkomycin spectrum, batch cultures were grown in 10ml nikkomycin-production medium in baffled 1 00-ml Erlenmeyer flasks on a rotatory shaker at 27°C. The production medium consisted of mannitol 3%, starch 1 %, soy bean meal 2% and yeast extract 1 %, pH 6.0.
Nikkomycin Determination The nikkomycin spectrum of the investigated strains was determined by analyzing culture filtrates by HPLCas described by Fiedler10. UVspectra of eluted nikkomycins were recorded by a photodiode array detector during the HPLCrun15). Nikkomycins in the culture broths were identified by their HPLC-retention times and their UVspectra which were compared to those of purified nikkomycins. Fig. 2 shows the UVspectrum of purified nikkomycin Kx which was corrected from that published by Fiedler15). In contrast to all other known nikkomycins with the 4-formylimidazolone base which have a single absorption maximumat 287 nm (Fig. 2) , nikkomycin Kx exhibit an additional absorption maximum at 267 nm.
Results
Isolation of Mutants Blocked in the Biosynthesis of the 4-Formyl-4-imidazoline-2-one Base Delzer et «/.16) reported that barbituric acid reacts with nikkomycins containing the 4-formylimidazolone base leading to red-colored products having an absorption maximumof 440 nm in water. Similar to the reaction of dimedone with aldehydes, two molecules of barbituric acid react with one molecule of nikkomycin (determined for nikkomycin X). This reaction was used as a basis to develop a method to screen for strains with a mutation affecting the biosynthesis of the 4-formylimidazolone base; about 3O~35 colonies derived from single mutagenized spores were streaked in patches on agar plates (85 mmin diameter) containing 30 ml HA medium and grown at 30°C for 2 days. Then, agar plugs of about 5 mmin diameter were cut out and incubated for 2 hours at 30°C on plates (85 mmin diameter) containing 10 ml 0.1 % barbituric acid, 0.7 % agarose, pH 7.0 adjusted with NaOH. Finally the developed color of the agar plugs was observed on the bottom of the barbituric acid plates. Clones producing nikkomycins with the 4-formylimidazolone base showed an orange color (wild type), while negative clones were yellow. Strains appearing to be negative after a second screening were cultivated in liquid production mediumand their nikkomycin spectrum was analyzed by HPLC.
Among18,000 clones tested, 26 showed a negative reaction with barbituric acid. As shown by HPLC, 25 of these strains did not produce any biologically active nikkomycins (Z, X, J and I) nor the inactive nucleoside structures, nikkomycins C and Cx, or the amino acid, nikkomycin D (Figs. 1  and 3A) . In contrast, the mutant Tii901/L9 formed nikkomycins Z and J containing uracil as base at concentrations similar to those produced by the wild type (about 450 mg/liter nikkomycin Z; 150 mg/liter nikkomycin J) but did not form nikkomycins with the 4-formylimidazolone base (Fig. 3B) . TU901/L9 produced nikkomycin X, when resting cells were fed purified nikkomycin Cx (data not shown).
Isolation of Mutants Blocked in the Biosynthesis of Nikkomycin D In a previous paper10) we described the mutant TU901/395 which produced nikkomycins Z, X (about 350mg/liter), J/I (about 150mg/liter) and also nikkomycin K (100 mg/liter) and O (250 mg/liter) which exhibit an altered amino acid17) (Fig. 1) . After isolating colonies derived from single spores or protoplasts of this mutant, only 6% among 120 investigated clones produced the complete nikkomycin spectrum of the parent strain, while 3 % were non-producers which did not form any known nikkomycin structures (Fig. 3A) . The 15 % of the clones had the nikkomycin spectrum of the wild type consisting of nikkomycin Z/X (800~900 mg/liter), J/I (300~400 mg/liter) and O (30 mg/liter) (Fig. 3C) . In contrast, 76% of the strains formed only nikkomycin Kz/Kx (10~100 mg/liter) and Oz/Ox (50~300 mg/liter) as biologically active structures. In addition, relatively high amounts of the nucleoside moieties nikkomycin C/Cx (600~800 mg/liter) were excreted, while nikkomycin D could not be detected in their culture filtrates. Fig. 3D shows the HPLCanalysis of the culture filtrate of Tu901/395-ll, a clone belonging to this class of mutants.
Furthermore, we isolated two strains, Tii901/AECl and AEC2, with an additional mutation affecting the hydroxylation reaction at the pyridyl ring of the amino acid moiety of nikkomycins. They were derived from Tu901/395-ll (Fig. 3D ) treated with UV365nm/MOPand selected for resistance to the lysine analog £-2-aminoetyhl-L-cysteine.
Tii901/AECl and AEC2 only formed nikkomycin Kz/Kx (200-300 mg/liter) and the nucleoside structures nikkomycin C/Cx (250 mg/liter) (Fig. 3E) . In addition, two unknownsubstances were accumulated in the culture broths of TU901/AEC1 and TU901/ AEC2which eluted as significant peaks at 2.15 minutes and 2.77 minutes. The isolation and chemical characterization of these compounds are in progress, since they may be precursors in nikkomycin biosynthesis.
Discussion
The described barbituric acid plate assay for the detection of nikkomycins containing the 4-formylimidazolone base can be employedto screen specifically for strains of S. tendae unable to synthesize the 4-formylimidazolone base. After NTGmutagenesis the frequency of isolation of these mutants was relatively low (0.0055 %). The mutant TU901/L9, which only produced nikkomycins with an uracil base, could form nikkomycin X when resting cells were fed purified nikkomycin Cx. Obviously TU901/L9 is able to form the peptide bond between the nucleoside moiety, nikkomycin Cx, and nikkomycin D. Although the enzymatic step blocked in the biosynthetic pathway from L-histidine to the 4-formylimidazolone base is not defined, Tii901/L9 is a suitable host for cloning nikkomycin biosynthetic genes which could then be subsequently screened in the barbituric acid assay. The mutants producing only nikkomycins K and O are obviously blocked in the biosynthesis of the C4-skeleton attached to the hydroxymethylene carbon of nikkomycin D. The alternative pathway leading to the 2-amino-4-hydroxy-4-pyridylbutyric acids seems to be less effective, since the mutants produced low amounts of nikkomycins K and O (400 mg/liter) and accumulated high levels of the nucleoside structures nikkomycins C and Cx. In contrast, revertants of Tii901/395 exhibiting the wild type nikkomycin spectrum (nikkomycins Z, X, J and I) synthesized up to 1,300 mg/liter of biologically active nikkomycins containing nikkomycin D. The hydroxylation occuring at the pyridyl residue during the biosynthesis of the amino acid moiety is specifically blocked in the mutants TU901/AEC1and Tii901/AEC2. As the MICs of nikkomycin Kz/Kx are about 100 times less than those of nikkomycins Z and X10), these mutants can also be used as hosts in cloning experiments for the isolation of nikkomycin biosynthetic genes with a screening for antifungal activity.
